We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca’s Tagrisso is First Project Orbis Drug Approved by UK Regulator
AstraZeneca’s Tagrisso is First Project Orbis Drug Approved by UK Regulator
The UK’s Medicines and Healthcare products Regulatory Agency has issued its first drug approval under Project Orbis, a joint program by the FDA, Canada, Australia, Switzerland, Singapore, Brazil and the UK for reviews of cancer treatments.